143 related articles for article (PubMed ID: 23091890)
21. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S
Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053
[TBL] [Abstract][Full Text] [Related]
22. Proliferative activity and p53 over-expression of ovarian epithelial tumors.
Kuwata T; Kitagawa M; Takemura T; Hirokawa K
Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593
[TBL] [Abstract][Full Text] [Related]
23. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Skirnisdottir I; Seidal T
Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
[TBL] [Abstract][Full Text] [Related]
24. S100A7, Jab1, and p27
Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
[TBL] [Abstract][Full Text] [Related]
25. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
[TBL] [Abstract][Full Text] [Related]
26. Expression of Jun activation domain-binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma.
Ito Y; Yoshida H; Nakamura Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
Pathology; 2005 Jun; 37(3):216-9. PubMed ID: 16175894
[TBL] [Abstract][Full Text] [Related]
27. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
[TBL] [Abstract][Full Text] [Related]
28. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice.
Tomoda K; Yoneda-Kato N; Fukumoto A; Yamanaka S; Kato JY
J Biol Chem; 2004 Oct; 279(41):43013-8. PubMed ID: 15299027
[TBL] [Abstract][Full Text] [Related]
29. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
Kamiński K; Putowski L; Oleszczuk J
Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.
Berchuck A; Kohler MF; Hopkins MP; Humphrey PA; Robboy SJ; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC
Gynecol Oncol; 1994 Feb; 52(2):232-6. PubMed ID: 7508877
[TBL] [Abstract][Full Text] [Related]
31. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
Wang F; Wang Y; Yu X; Yang D; Wang Z; Lu C; Yuan Z; Xiao M; Shen A
J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
[TBL] [Abstract][Full Text] [Related]
32. [Expression and Clinical Significance of Numb and P53 Proteins in Epithelial Ovarian Carcinoma].
Xu M; He HJ; Zhang H; Wang A; Chen J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):76-80. PubMed ID: 28612563
[TBL] [Abstract][Full Text] [Related]
33. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
Lee EW; Oh W; Song HP; Kim WK
BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
[TBL] [Abstract][Full Text] [Related]
36. Expression of cell regulatory proteins in ovarian borderline tumors.
van Haaften-Day C; Russell P; Boyer CM; Kerns BJ; Wiener JR; Jensen DN; Bast RC; Hacker NF
Cancer; 1996 May; 77(10):2092-8. PubMed ID: 8640675
[TBL] [Abstract][Full Text] [Related]
37. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
Brain Tumor Pathol; 2012 Jan; 29(1):3-9. PubMed ID: 21837501
[TBL] [Abstract][Full Text] [Related]
38. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53 protein in borderline epithelial ovarian tumors: a clinicopathologic study of 39 cases.
Darai E; Walker-Combrouze F; Mlika-Cabanne N; Feldmann G; Madelenat P; Scoazec JY
Eur J Gynaecol Oncol; 1998; 19(2):144-9. PubMed ID: 9611054
[TBL] [Abstract][Full Text] [Related]
40. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
